Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study
収録刊行物
-
- Respiratory Research
-
Respiratory Research 15 (1), 2014-07-11
Springer Science and Business Media LLC